Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Columbus OH, Cleveland OH, London, Chicago IL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase3, Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Columbus OH, Grand Rapids MI, New York NY, Mineola NY,
Cognitive Status After Removal of Skull Base Meningioma
for
Meningioma, Skull Base Meningioma, Frontal Meningioma,
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18 - 70+
Code: NCT04635657
Recruiting
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Columbus OH, Canton OH, Cleveland OH, Pittsburgh PA,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase1, Phase2, Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Location: Columbus OH, Hershey PA, Richmond VA, Durham NC,
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT03567889
Phase3, Recruiting
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Columbus OH, Richmond VA, Baltimore MD, Durham NC,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
Met Non Small Cell Cancer Registry (MOMENT)
for
Cancer
Location: Columbus OH, Toronto, Ottawa, Quebec,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 0+
Code: NCT05376891
Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers